June 11, 2020 / 11:17 AM / a month ago

BRIEF-Magenta Therapeutics Announces Collaboration With The National Marrow Donor Program

June 11 (Reuters) - Magenta Therapeutics Inc:

* MAGENTA THERAPEUTICS ANNOUNCES COLLABORATION WITH THE NATIONAL MARROW DONOR PROGRAM/BE THE MATCH TO ADVANCE DEVELOPMENT OF MGTA-145 FOR FIRST-LINE MOBILIZATION OF STEM CELLS FROM HEALTHY DONORS AND SUBSEQUENT PATIENT TRANSPLANT

* MAGENTA THERAPEUTICS INC - PLAN TO INITIATE A PHASE II TRIAL OF MGTA-145 IN MATCHED RELATED DONORS FOR PATIENTS UNDERGOING ALLOGENEIC TRANSPLANT

* MAGENTA THERAPEUTICS - COLLABORATION FOCUSES ON CLINICAL DEVELOPMENT OF MGTA-145 FOR STEM CELL MOBILIZATION IN ALLOGENEIC TRANSPLANT

* MAGENTA THERAPEUTICS INC - MAGENTA WILL RETAIN ALL COMMERCIAL RIGHTS TO MGTA-145 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below